L'Oreal SA

Explore why L’Oréal’s shares dipped yet fundamentals stay solid: premium strategy, margin pressure, ESG risks, and digital lag.

How L’Oréal’s 20% stake in Galderma reshapes the skin‑care market.

Discover how L’Oréal’s 20% stake in Galderma could unlock dermatology growth, synergies, and new markets while navigating regulatory and brand risks.

Discover why L’Oréal shares edged higher amid a European rally—boosted by global demand, strong brand equity, and macro‑economic optimism.

L’Oréal has acquired Kering’s €4 billion beauty business, expanding its fragrance division and luxury offerings, and positioning itself for growth and increased competitiveness in the cosmetics and fashion industries.

L’Oreal’s FY 2025 results show a 22.6% increase in net profit and 6.25% growth in net sales, but the company’s proposed acquisition of a significant stake in Italian luxury fashion house Armani poses substantial regulatory, integration, and market r…

L’Oréal’s stock price has remained stable, closing at 396.7 EUR, despite market fluctuations, reflecting the company’s enduring presence in the industry.

L’Oreal’s stock price declined by over 1% due to market uncertainty, but the company is adapting with a new initiative in China that aims to redefine beauty and position itself for long-term success.

L’Oreal SA navigates turbulent market with strategic moves, including exploring ways to mitigate tariffs and capitalizing on an improving US market outlook.

L’Oreal’s stock rating has been upgraded by JPMorgan due to an improving US market outlook, providing a welcome boost to the company’s investor confidence.